InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Simeon George
14 Oct 2026
Director
Sold after exercise
14,514
$49.63
$720.37K
James R. Kasinger
6 Oct 2026
General Counsel and Secretary
Sold after exercise
1,990
$60.04
$119.48K
James R. Kasinger
22 Sep 2026
General Counsel and Secretary
Sold after exercise
10,400
$60.24
$626.46K
Ali Behbahani
17 Sep 2026
Director
Sold after exercise
13,679
$57.09
$780.94K
Raju Prasad
22 Jan 2026
Chief Financial Officer
Sold after exercise
34,972
$60.19
$2.10M
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
5,763
$60.21
$347.01K
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
5,004
$60.00
$300.24K
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
18,933
$60.18
$1.14M
Show all 30 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 8
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 415,520
History held since 20 Oct 2016